Alana B. McNulty's most recent trade in Janux Therapeutics Inc was a trade of 11,667 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Janux Therapeutics Inc | Alana B. McNulty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,667 | 11,667 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Alana B. McNulty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 3,750 | 6,250 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Alana B. McNulty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,350 | 8,350 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Alana B. McNulty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2,500 | 2,500 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Alana B. McNulty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Alana B. McNulty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Alana B. McNulty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 120,713 | 120,713 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 113,470 | 113,470 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 96,570 | 96,570 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 96,570 | 96,570 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 91,826 | 91,826 | - | - | Earn-out Right | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 65,185 | 65,185 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 48,768 | 48,768 | - | - | Common Stock | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 43,456 | 43,456 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Alana B. McNulty | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 38,628 | 38,628 | - | - | Stock Option (Right to Buy) |